Aberdeen Group’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $8.53M | Buy |
|
|||||
|
2024
Q4 | $9.4M | Sell |
|
|||||
|
2024
Q3 | $11.9M | Sell |
|
|||||
|
2024
Q2 | $12.5M | Sell |
|
|||||
|
2024
Q1 | $15.1M | Sell |
|
|||||
|
2023
Q4 | $23.3M | Sell |
|
|||||
|
2023
Q3 | $23.7M | Sell |
|
|||||
|
2023
Q2 | $38.6M | Sell |
|
|||||
|
2023
Q1 | $42.8M | Sell |
|
|||||
|
2022
Q4 | $40.1M | Buy |
|
|||||
|
2022
Q3 | $28.3M | Buy |
|
|||||
|
2022
Q2 | $33M | Buy |
|
|||||
|
2022
Q1 | $40.3M | Sell |
|
|||||
|
2021
Q4 | $48.8M | Buy |
|
|||||
|
2021
Q3 | $41.3M | Buy |
|
|||||
|
2021
Q2 | $37.3M | Buy |
|